(S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine) manufacturers
|
| | (S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine) Basic information |
| Product Name: | (S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine) | | Synonyms: | (S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine);(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine;Rotigotine InterMediate;(S)-5-Methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-aMine;2-NaphthalenaMine, 1,2,3,4-tetrahydro-5-Methoxy-N-propyl-, (S)-;(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine HCl;2-Naphthalenamine, 1,2,3,4-tetrahydro-5-methoxy-N-propyl-, (2S)-;(2S)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine | | CAS: | 101403-24-1 | | MF: | C14H21NO | | MW: | 219.32 | | EINECS: | | | Product Categories: | APIs Intermediate | | Mol File: | 101403-24-1.mol |  |
| | (S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine) Chemical Properties |
| Boiling point | 346.1±42.0 °C(Predicted) | | density | 1.01±0.1 g/cm3(Predicted) | | solubility | soluble in Methanol | | pka | 10.26±0.20(Predicted) | | InChI | InChI=1S/C14H21NO/c1-3-9-15-12-7-8-13-11(10-12)5-4-6-14(13)16-2/h4-6,12,15H,3,7-10H2,1-2H3/t12-/m0/s1 | | InChIKey | ICJPCRXVYMMSJY-LBPRGKRZSA-N | | SMILES | C1C2=C(C(OC)=CC=C2)CC[C@@H]1NCCC |
| | (S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine) Usage And Synthesis |
| Uses | (S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine is an intermediate in the production of antipsychotic agents and antiparkinson medications. (S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine Di-p-toluoyl-L-tartaric Acid Salt is an impurity in the synthesis of ent-Rotigotine (R700705), which is a non-ergot dopamine agonist drug and is indicated for the treatment of Parkinson’s disease. |
| | (S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine) Preparation Products And Raw materials |
|